U.S. FDA grants Orphan Drug Designation to Deramiocel for the treatment of Becker Muscular Dystrophy, broadening Capricor’s ...

Researchers have developed a novel method for simultaneously recording action potentials (APs)—temporary changes in ...

Capricor shares four-year data showing Deramiocel slowed DMD progression and preserved function, with maintained safety in long-term use.

Sarepta Therapeutics’ gene therapy to treat limb girdle muscular dystrophy type 2E/R4 gets US FDA platform technology designation: Cambridge, Massachusetts Friday, June 6, 2025, ...

U.S. FDA successfully completed Pre-License Inspection; Company expects facility will meet all requirements to support licensure Advisory Committee meeting scheduled for July 30, 2025 Mid-cycle ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided a safety ...

Duchenne muscular dystrophy families are sharing stories about Elevidys complications on social media. But they aren’t ...

I am upgrading Dyne Therapeutics stock to a 'Buy' rating due to promising late-stage DM1 and DMD drug candidates and ...

After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price ...

Garlic extract may reduce heart attack risk by 40%. Discover how this natural compound protects your heart and arteries from ...

In video games, all players usually need to do to stay healthy is to drink the occasional healing potion or perhaps grab a ...

Learn about vasovagal syncope, the most common cause of fainting affecting 40% of adults. Discover symptoms, triggers, and ...